Skip to main content

Breadcrumb

  1. Home

PMS2

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:51
  • Read more about PMS2

PD-L1 22C3 FDA (KEYTRUDA®) for TNBC (Breast)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:51
  • Read more about PD-L1 22C3 FDA (KEYTRUDA®) for TNBC (Breast)

PD-L1 LDT

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:51
  • Read more about PD-L1 LDT

PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:51
  • Read more about PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC

p53

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:51
  • Read more about p53

PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:51
  • Read more about PD-L1 SP142 FDA (TECENTRIQ®) for NSCLC

PD-L1 28-8 FDA for NSCLC

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:51
  • Read more about PD-L1 28-8 FDA for NSCLC

PD-L1 22C3 FDA for NSCLC

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:51
  • Read more about PD-L1 22C3 FDA for NSCLC

PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head & Neck)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:51
  • Read more about PD-L1 22C3 FDA (KEYTRUDA®) for HNSCC (Head & Neck)

PD-L1 22C3 FDA (KEYTRUDA®) for ESCC (Esophageal Squamous Cell Carcinoma)

Submitted by Anonymous (not verified) on Tue, 03/25/2025 - 15:51
  • Read more about PD-L1 22C3 FDA (KEYTRUDA®) for ESCC (Esophageal Squamous Cell Carcinoma)

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 51
  • Page 52
  • Page 53
  • Page 54
  • Page 55
  • Page 56
  • Page 57
  • Page 58
  • Page 59
  • …
  • Next page Next
  • Last page Last
Subscribe to